Clinical Characteristics, Patient-Reported Outcomes, and Previous Therapeutic Management of Patients with Uncontrolled Neuropathic Pain Referred to Pain Clinics
Table 4
Treatment of neuropathic pain by specialty.
Characteristic
Overall
Primary care
Traumatology
Neurology
Neurosurgery
Rehabilitation
Rheumatology
Other surgeries
Other specialties
Number of previous treatments
Mean ± SD
1, %
11.9
15.5
12.7
5.6
5.8
9.1
3.3
17.6
10.9
2, %
27.4
23.6
24.9
27.8
28.8
27.3
43.3
35.3
31.5
3, %
25.6
29.1
24.9
27.8
30.8
27.3
20.0
21.6
27.2
>4, %
35.1
31.8
37.6
38.9
34.6
36.4
33.3
25.5
30.4
Treatment at the time of inclusion, %
Paracetamol
25.0
19.1
33.9
13.0
15.4
18.2
26.7
25.5
22.8
NSAIDs
40.1
33.6
47.5
27.8
36.5
54.5
50.0
43.1
25.0
Opiods
39.6
41.8
40.3
38.9
55.8
33.3
53.3
17.6
35.9
Tramadol
29.5
28.2
29.4
29.6
48.1
24.2
43.3
13.7
28.3
Others
14.8
16.4
14.9
18.5
15.4
9.1
6.7
7.8
15.2
AED
54.1
56.4
48.4
81.5
69.2
48.5
43.3
41.2
56.5
Pragabalin
26.7
21.8
29.4
33.3
28.8
24.2
23.3
23.5
25.0
Gabapentin
23.5
28.2
19.0
31.5
34.6
15.2
10.0
17.6
30.4
Carbamazepine/oxcarbazepine
6.3
9.1
0.5
31.5
3.8
6.1
3.3
3.9
5.4
Other
4.4
2.7
3.2
7.4
11.5
6.1
6.7
0.0
5.4
Antidepressants
19.7
24.5
15.8
31.5
17.3
9.1
20.0
17.6
25.0
Duloxetine
5.3
5.5
5.4
1.9
5.8
3.0
10.0
3.9
6.5
Tricyclics
11.3
13.6
6.3
25.9
11.5
6.1
6.7
11.8
17.4
Other
4.2
5.5
4.1
5.6
1.9
3.0
10.0
2.0
3.3
Other drugs
47.6
47.3
46.6
51.9
34.6
39.4
46.7
51.0
54.3
Nonpharmacological
52.0
46.4
58.8
44.4
51.9
81.8
53.3
47.1
39.1
AED: antiepileptic drugs: NSAIDs: nonsteroidal anti-inflammatory drugs; SD: standard deviation.
